148 related articles for article (PubMed ID: 18941746)
1. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy.
Dinter DJ; Neff WK; Klaus J; Böhm C; Hastka J; Weiss C; Schoenberg SO; Metzgeroth G
Ann Hematol; 2009 May; 88(5):457-64. PubMed ID: 18941746
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
3. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
4. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies.
Minarik J; Krhovska P; Hrbek J; Pika T; Bacovsky J; Herman M; Scudla V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):305-9. PubMed ID: 26740048
[TBL] [Abstract][Full Text] [Related]
6. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
8. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography.
Mahnken AH; Wildberger JE; Gehbauer G; Schmitz-Rode T; Blaum M; Fabry U; Günther RW
AJR Am J Roentgenol; 2002 Jun; 178(6):1429-36. PubMed ID: 12034612
[TBL] [Abstract][Full Text] [Related]
9. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
10. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
11. [Bone disease in multiple myeloma. A study of 237 cases].
Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
[TBL] [Abstract][Full Text] [Related]
12. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
15. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
Baur-Melnyk A; Reiser M
Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
[TBL] [Abstract][Full Text] [Related]
16. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma.
Baur-Melnyk A; Reiser MF
Semin Musculoskelet Radiol; 2009 Jun; 13(2):111-9. PubMed ID: 19455474
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
[TBL] [Abstract][Full Text] [Related]
20. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
